99 related articles for article (PubMed ID: 748802)
1. Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.
Bogden AE; Esber HJ
Natl Cancer Inst Monogr; 1978 Dec; (49):97-100. PubMed ID: 748802
[TBL] [Abstract][Full Text] [Related]
2. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
3. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
Yron I; Cohen D; Robinson E; Haber M; Weiss DW
Cancer Res; 1975 Jul; 35(7):1779-90. PubMed ID: 1093676
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
Bogden AE; Esber HJ; Taylor DJ; Gray JH
Cancer Res; 1974 Jul; 34(7):1627-31. PubMed ID: 4857731
[No Abstract] [Full Text] [Related]
5. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
Greager JA; Baldwin RW
Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
[No Abstract] [Full Text] [Related]
6. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
Lee YT
Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
8. The concept of induction and elicitation as an immunotherapeutic approach.
Bogden AE; Esber HJ
Natl Cancer Inst Monogr; 1978 Dec; (49):365-7. PubMed ID: 748794
[TBL] [Abstract][Full Text] [Related]
9. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL
J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
[TBL] [Abstract][Full Text] [Related]
10. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
van Dierendonck JH; Cornelisse CJ; van der Linden PW; van Putten LM; van de Velde CJ
Cancer Res; 1987 Aug; 47(15):4093-8. PubMed ID: 3607751
[TBL] [Abstract][Full Text] [Related]
12. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.
Sparks FC; O'Connell TX; Lee YT
Surg Forum; 1973; 24():118-21. PubMed ID: 4618633
[No Abstract] [Full Text] [Related]
14. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
15. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
[TBL] [Abstract][Full Text] [Related]
16. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.
Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM
Cancer Treat Rep; 1978 Oct; 62(10):1471-88. PubMed ID: 709550
[TBL] [Abstract][Full Text] [Related]
17. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
18. Effects of hyperthermia on primary and metastatic tumor growth and host immune response in rats.
Schechter M; Stowe SM; Moroson H
Cancer Res; 1978 Mar; 38(3):498-502. PubMed ID: 626954
[TBL] [Abstract][Full Text] [Related]
19. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
Vaage J
Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
Rabbani SA; Gladu J
Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
